Remy Sukhija is Chief Commercial Officer of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 15,001 shares of MDGL, which is worth approximately $4.15 Million. The most recent transaction as insider was on Jan 16, 2023, when has been sold 15,001 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K
0% 3M change
0% 12M change
Total Value Held $4.15 Million

Remy Sukhija Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 16 2023
BUY
Grant, award, or other acquisition
-
15,001 Added 50.0%
15,001 Common Stock
Dec 23 2022
SELL
Open market or private sale
$8,258,099 $275.27 p/Share
30,000 Reduced 100.0%
0 Common Stock
Dec 23 2022
BUY
Exercise of conversion of derivative security
$1,807,800 $60.26 p/Share
30,000 Added 50.0%
30,000 Common Stock
RS

Remy Sukhija

Chief Commercial Officer
West Conshohocken, PA

Track Institutional and Insider Activities on MDGL

Follow MADRIGAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Track Activities on MDGL